HIGH-DOSE, PULSE INTRAVENOUS METHYLPREDNISOLONE ENHANCES FC-GAMMA-RECEPTOR MEDIATED MONONUCLEAR PHAGOCYTE FUNCTION IN SYSTEMIC LUPUS-ERYTHEMATOSUS

被引:18
|
作者
SALMON, JE
KAPUR, S
MERYHEW, NL
RUNQUIST, OA
KIMBERLY, RP
机构
[1] UNIV MINNESOTA, DEPT MED, MINNEAPOLIS, MN 55455 USA
[2] HAMLINE UNIV, DEPT CHEM, ST PAUL, MN 55104 USA
来源
ARTHRITIS AND RHEUMATISM | 1989年 / 32卷 / 06期
关键词
D O I
10.1002/anr.1780320609
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:717 / 725
页数:9
相关论文
共 50 条
  • [41] PNEUMATOSIS-CYSTOIDES-INTESTINALIS IN SYSTEMIC LUPUS-ERYTHEMATOSUS WITH INTESTINAL VASCULITIS - TREATMENT WITH HIGH-DOSE PREDNISONE
    CABRERA, GE
    SCOPELITIS, E
    CUELLAR, ML
    SILVEIRA, LH
    MENA, H
    ESPINOZA, LR
    CLINICAL RHEUMATOLOGY, 1994, 13 (02) : 312 - 316
  • [42] EFFECTS OF TOTAL-LYMPHOID IRRADIATION (TLI) AND HIGH-DOSE CYCLOPHOSPHAMIDE TREATMENT OF SYSTEMIC LUPUS-ERYTHEMATOSUS
    KAPELLE, A
    VOLK, HD
    SCHLAAK, B
    HIEPE, F
    MIELKE, F
    APOSTOLOFF, W
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 1988, 47 (04): : 283 - 283
  • [43] High-Dose Cyclophosphamide Versus Monthly Intravenous Cyclophosphamide for Systemic Lupus Erythematosus A Prospective Randomized Trial
    Petri, Michelle
    Brodsky, Robert A.
    Jones, Richard J.
    Gladstone, Douglas
    Fillius, Michael
    Magder, Laurence S.
    ARTHRITIS AND RHEUMATISM, 2010, 62 (05): : 1487 - 1493
  • [44] MODIFICATION OF DISEASE IN THE NZB/NZW MODEL OF SYSTEMIC LUPUS-ERYTHEMATOSUS TREATED WITH HIGH-DOSE INTERLEUKIN-2
    OWEN, KL
    WALKER, SE
    LABORATORY ANIMAL SCIENCE, 1986, 36 (05): : 589 - 589
  • [45] EFFECTS OF MEGA DOSE INTRAVENOUS METHYLPREDNISOLONE (IVMP) ON T4/T8 RATIO IN PATIENTS WITH SYSTEMIC LUPUS-ERYTHEMATOSUS (SLE)
    HARISDANGKUL, V
    ROCKHOLD, L
    CRUSE, JM
    LEWIS, R
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1989, 45 (02) : 177 - 177
  • [46] RETICULOENDOTHELIAL SYSTEM FC RECEPTOR FUNCTION IN SYSTEMIC LUPUS-ERYTHEMATOSUS (SLE) - DIFFERENCES BETWEEN RENAL AND NON-RENAL SUBSETS
    PARRIS, TM
    KIMBERLY, RP
    INMAN, RD
    DAVEY, MP
    KORNGOLD, L
    CLINICAL RESEARCH, 1981, 29 (01): : A160 - A160
  • [47] A DOUBLE-BLIND CONTROLLED TRIAL OF HIGH-DOSE VERSUS LOW-DOSE METHYL PREDNISOLONE INFUSIONS IN SYSTEMIC LUPUS-ERYTHEMATOSUS
    EDWARDS, JCW
    SNAITH, ML
    ISENBERG, DA
    BRITISH JOURNAL OF RHEUMATOLOGY, 1986, 25 : 82 - 82
  • [48] CELL-FREE FC-GAMMA RECEPTOR III IN SERA FROM PATIENTS WITH SYSTEMIC LUPUS-ERYTHEMATOSUS - CORRELATION WITH CLINICAL AND BIOLOGICAL FEATURES
    HUTIN, P
    LAMOUR, A
    PENNEC, YL
    SOUBRANE, C
    DIEN, G
    KHAYAT, D
    YOUINOU, P
    INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 1994, 103 (01) : 23 - 27
  • [49] RETICULOENDOTHELIAL SYSTEM FC-RECEPTOR FUNCTION IN PATIENTS WITH IMMUNE THROMBOCYTOPENIA AFTER TREATMENT WITH HIGH-DOSE INTRAVENOUS IMMUNOGLOBULIN
    BUDDE, U
    AUCH, D
    NIESE, D
    SCHAFER, G
    RESKE, SN
    SCHMIDT, RE
    SCANDINAVIAN JOURNAL OF HAEMATOLOGY, 1986, 37 (02): : 125 - 129
  • [50] Limbic encephalitis in a patient with systemic lupus erythematosus successfully treated with high-dose glucocorticoids and intravenous cyclophosphamide therapy: the potential pathogenicity of anti-glutamate receptor antibodies
    Tsuchiya, Haruka
    Iwasaki, Yukiko
    Shoda, Hirofumi
    Takahashi, Yukitoshi
    Fujio, Keishi
    MODERN RHEUMATOLOGY CASE REPORTS, 2021, 5 (02) : 250 - 253